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Abstract Cashew plant (Anacardium occidentale L.) is the
most relevant species of the Anacardium genus. It presents
high economic value since it is widely used in human nutrition
and in several industrial applications. Cashew nut is a well-
appreciated food (belongs to the tree nut group), being widely
consumed as snacks and in processed foods by the majority of
world’s population. However, cashew nut is also classified as
a potent allergenic food known to be responsible for triggering
severe and systemic immune reactions (e.g. anaphylaxis) in
sensitised/allergic individuals that often demand epinephrine
treatment and hospitalisation. So far, three groups of allergenic
proteins have been identified and characterised in cashew nut:
Ana o 1 and Ana o 2 (cupin superfamily) and Ana o 3
(prolamin superfamily), which are all classified as major aller-
gens. The prevalence of cashew nut allergy seems to be rising
in industrialised countries with the increasing consumption of
this nut. There is still no cure for cashew nut allergy, as well as
for other food allergies; thus, the allergic patients are advised
to eliminate it from their diets. Accordingly, when carefully
choosing processed foods that are commercially available, the
allergic consumers have to rely on proper food labelling. In
this sense, the control of labelling compliance is much needed,
which has prompted the development of proficient analytical
methods for allergen analysis. In the recent years, significant
research advances in cashew nut allergy have been accom-
plished, which are highlighted and discussed in this review.
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Introduction
Cashew plant (Anacardium occidentale L.) belongs to the
Anacardiaceae family, which comprises nine species of the
Anacardium genus [1]. A. occidentale is the most relevant in
terms of economic interest, although other trees and shrubs of
this genus have begun to gain special attention. Additional
data on each species is presented in Table 1, namely their
geographical distribution, applications and potential allergenic
proteins.
A. occidentale is a tropical evergreen tree that is well
known for its fruits and seeds. The cashew fruit (cashew
apple) is actually a swollen peduncle (pseudofruit) with sweet
flavour and aroma. The pulpy and juicy part of cashew apple
is highly popular, being consumed as juices, jams and
alcoholic beverages [2, 3]. The cashew nut (seed) grows
externally, inside a hard shell, at the end of the peduncle.
The hard shell is composed by two layers that form a
honeycomb structure containing an oily substance (phenolic
cashew nut shell liquid), which presents several industrial
applications, namely in plastic, paint, resin and surface coating
industries [2]. Inside the hard shell and protected from the oily
substance lays the kernel (cashew nut) that is a rich source of
protein, carbohydrate and triglyceride oil. Cashew nuts are
normally consumed roasted and salted, being worldwide
appreciated as snacks.
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A. occidentale species originated from South America (e.g.
Brazil, Venezuela), but it is currently cultivated in several
countries of Africa and Asia (e.g. Vietnam, India, United
Republic of Tanzania, Indonesia) [6]. In 2013, Vietnam was
the main producer of cashew nut with shell, thus assuring
25 % of its global production. In the same year and in terms
of trade, cashew nut ranked second place just behind almond
[6]. Included in the tree nuts, cashew nut is also related to
several beneficial health effects that are commonly attributed
to this group of nuts. Accordingly, cashew nut and its co-
products have a long history of worldwide application in
traditional medicine for the treatment of different health
conditions, such as asthma, diabetes, skin infections and
inflammation, amongst others (Table 1) [3]. However, no
clinical studies have yet proven its actual medicinal efficacy [7].
Owing to the health food claims attributed by the World
Health Organization and the Food and Agriculture
Organization (WHO/FAO) to tree nuts [8], the consumption
of cashew nut and other tree nuts has been increasing in the
past years. However, cashew (nut and fruit) can also
represent a concrete health risk for a small but rather
significant part of the world’s population, namely the
food-sensitised/allergic individuals.
With the increasing awareness that food allergies represent
an important public health problem, legal measures have been
established to protect the life of those individuals. In 1985, the
Codex Alimentarius Commission issued a recommendation
for mandatory labelling of pre-packaged foods susceptible of
containing potentially allergenic ingredients. Accordingly, a
list of priority allergenic foods (tree nuts, peanuts, gluten-
containing cereals, soybean, fish, eggs, milk and crustaceans)
and sulphites was proposed by the Codex Alimentarius
Commission [9]. Within the European Union (EU), the first
priority list was issued by the Directive 2003/89/EC [10],
adding sesame, celery and mustard to the previous list [9],
totalising 12 groups of allergenic foods. Since then, the EU
has established legislation increasing the priority list of aller-
gens to 14 groups (by adding molluscs and lupine) that are
required to be emphasised from the rest of the ingredients
enumerated in processed foods, regardless of their quantity
[11, 12]. Using the Codex Alimentarius Commission and/or
the EU standards as guidelines, many countries have adopted
allergen labelling regulatory frameworks [13, 14]. Owing to
the fact that tree nuts are one of the eight groups responsible
for a great number of allergic reactions, they are included in
the list of allergenic foods with mandatory labelling in most
countries/regions (e.g. USA, Canada, EU), with exception of
Japan and Korea [13, 14].
In the recent years, significant research advances in cashew
nut allergy, namely prevalence, diagnosis, immunotherapy,
clinical relevance and thresholds, as well as biochemical
characterisation of cashew nut allergens, processing and
digestibility studies, management and method development
for its detection, have been achieved. The research progresses
in cashew nut allergy have been summarised and discussed in
this review.
Epidemiology of Cashew Allergy
The definition of the prevalence of food allergies has been
estimated on the basis of different indicators. Amongst them,
surveys and questionnaires have been widely used to predict
the prevalence of several food allergies. However, the
retrieved information must be carefully evaluated since the
sensitised/allergic individuals might overrate self-allergic
symptoms. To overcome these drawbacks, more objective
indicators, such as provocation food tests (open food
challenges (OFC) and double-blind placebo-controlled food
challenges (DBPCFC)) or in vitro (serum IgE) and in vivo (skin
prick tests (SPT)) diagnostic tools, to assess food sensitisation
are recommended [15]. However, OFC and DBPCFC studies
are more difficult to perform since their assessment is highly
dependent on the collaboration of the allergic individuals.
So far, there are several studies reporting prevalence data
about tree nut allergies, but only a few specify information
regarding individual nuts (e.g. cashew nut). Additionally,
most of the reports involve small geographical regions (e.g.
city, country), which retrains a broad overview about the real
prevalence of cashew nut or other food allergies. Literature
reporting the prevalence of cashew nut allergy is available for
some countries in Europe, the USA and Australia, but no
information could be retrieved from emergent economies
(Asia or Africa).
Like other nuts, the prevalence of cashew nut allergy varies
from region to region, presenting its highest reported inci-
dence in the USA [16]. A voluntary registration involving
5149 participants with peanut and tree nut allergies from 48
states was established in 1997 to evaluate their prevalence in
the USA. On the basis of a structured questionnaire that
encompassed peanut and different nuts, it was possible to
estimate that walnut (34 %) and cashew nut (20 %) allergies
presented the highest incidence rate amongst allergic patients
[17]. Using more objective indicators, such as SPT and
DBPCFC, Fleischer et al. [18] reported high prevalence of
walnut and cashew nut allergies, both with 30 % in a USA
test population of 101 patients with previous clinical diagnosis
of tree nut allergies.
Besides USA, cashew nut allergy also seems to be epide-
miologically increasing in other regions over the past years,
namely in Northern Europe [19, 20]. A study using clinical
records from a hospital in Uppsala County (Sweden) over a
10-year period (2001–2010) evidenced that peanuts and tree
nuts accounted for 50 % of the 703 food allergic cases in
children (<18 years), being more frequently associated with
epinephrine treatment and hospitalisation. Over the same
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period, the estimated prevalence of cashew nut allergy was
6 % of food allergic individuals, with reports of increasing
frequency and severity of episodes caused by cashew nut in-
gestion [19]. In a different region of Sweden (Stockholm
County), similar data could be retrieved from three paediatric
hospitals in 2007. Accordingly, 15 % of the reported food
allergies in children were attributed to tree nuts. From those,
5 %were triggered by cashew nut ingestion with most patients
experiencing anaphylaxis [20]. In a 3-year follow-up study
involving 139 tree nut allergic adults from Utrecht
(Netherlands), cashew nut allergy was estimated with a
prevalence of 20 % [21]. In France, Moneret-Vautrin [22]
estimated an incidence of 10.3 % of cashew nut allergy on a
test population of 141 patients, reporting that the number of
anaphylaxis cases increased from 3 to 9 % between 2003 and
2007, respectively.
In a 5-year study (1999–2003) based on clinical records
from a paediatric hospital in Australia (Melbourne), peanut
(18 %) and cashew nut (13 %) were the most common cause
for anaphylaxis in children [23]. Similar prevalence of cashew
nut allergy (12.6 %)was described byDavoren and Peake [24]
using clinical reports of a test population comprising 213
peanut and tree nut allergic children (<18 years) from
Brisbane (Australia) during a period of 42 months.
Moreover, in patients with diagnosed cashew nut allergy,
more than 74 % had experienced severe and life-threatening
episodes, such as anaphylaxis [24].
Diagnosis, Therapy and Immunotherapy
Cashew nut allergy is a classical IgE-mediated disorder. The
ingestion of cashew nut seems to be the principal sensitisation
path for its allergy, althoughmechanisms associated with poor
skin barrier function (atopic dermatitis) and loss of function in
the filaggrin gene have been also highlighted as increasing
risk factors for the development of cashew nut and other food
allergies [25, 26]. Like for most of food allergies, the initial
diagnosis of cashew nut allergy is usually built on the basis of
a clear definition of a medical history [27, 28]. Accordingly,
several aspects, such as the amount of ingested cashew nut,
the type of clinical presentations and organs/systems (skin,
gastrointestinal or respiratory) affected, the temporal
association between ingestion and the appearance of the first
observable symptoms and the symptoms after eating similar
foods, must be considered [27].
Following a record of medical history, diagnostic testing
methods, namely the use of in vivo SPT and/or in vitro
fluorescent-enzyme immunoassays (FEIA-CAP) or
radioallergosorbent tests (RAST), are recommended. The
SPT are performed by placing a small amount of the allergen
into the skin, eliciting a localised allergic reaction in the form
of a wheal at the testing site, whilst the FEIA-CAP and RAST
are based on the detection of specific IgE in serum. However,
these tests can only be considered as mere indicators of sen-
sitisation rather than truly predictive tools for food allergy. In
spite of presenting high sensitivities, negative results of the
diagnostic in vivo and/or in vitro tests cannot be considered
for allergy exclusion [29]. More recently, allergen microar-
rays, such as ImmunoCAP ISAC (diagnostic testing,
Thermo Fisher Scientific, Waltham, MA, USA) or the
MeDALL allergen-chip based platforms, have been advanced
as excellent tools for the simultaneous detection of multiple
allergen-specific IgE towards a large number of clinically
relevant allergens [30].
Regarding cashew nut, reports suggest that a wheal diameter
over 3 mm in SPT [25, 31, 32] and/or a value ≥0.35 kUA/L in
immunoCAP FEIA test can be indicative of allergy [21, 25, 33].
Mean values of wheal diameter of 7 mm (3–16 mm) and
8.5 mm (6.5–10 mm) were reported by Rancé et al. [25] and
Clark et al. [31] for children (<18) with medical history of
cashew nut allergy. To increase the accuracy of the SPT, the
area of the allergen-induced wheal can be compared with the
area of a histamine-induced wheal size (as positive control) to
correct for skin histamine sensitivity. The ratio is defined as
histamine equivalent prick (HEP) index [34]. Considering an
average wheal diameter over 3 mm and HEP index area ≥0.4
as baseline for positive sensitization, van der Valk et al. [32]
reported a mean value of 3.02 of HEP index (range 0–15.16)
in 164 of cashew nut allergic children.
Using the immunoCAP FEIA test, the mean values for
cashew nut-specific IgE described by Rancé et al. [25], van
der Valk et al. [32], andMaloney et al. [33] were 3.1, 3.72, and
5.5 kUA/L, respectively. Recombinant Ana o 3 has been
reported as a highly accurate diagnostic marker for cashew
nut allergy, showing higher sensitivity and specificity levels
(93.7 and 94.4 %, respectively) over the conventional whole
cashew nut extract (95.2 and 58.3 %, respectively) [35].
Additionally, the recombinant Ana o 3 was also considered an
excellent diagnostic marker for pistachio allergy with similar
sensitivity and specificity levels of cashew nut diagnosis. For
rAna o 3, an optimal cutoff point of 0.16 kUA/L was reported
as indicative for cashew nut and pistachio allergies [35].
Besides SPTand serum-specific IgE tests, oral provocation
tests such as OFC or DBPCFC are considered the Bgold
standard^ tools to identify allergenic foods (e.g. cashew nut)
and/or to confirm the allergy [28]. In general, individuals pre-
senting a convincing medical history of cashew nut allergy,
SPT of wheal diameter over 3 mm (HEP index ≥0.4) and/or
serum-specific IgE of 0.35 kUA/L are often purposed for oral
provocation tests (DBPCFC or OFC) with increasing doses of
cashew nut [32, 34]. The oral provocation tests are normally
discontinued and considered positives when objective symp-
toms occur, when severe subjective symptoms persist (>1 h)
or when subjective symptoms re-appear after second dose of
the same challenge material [32]. Patients with negative test
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challenges are frequently advised to introduce cashew nut at
home following a defined schedule with increasing doses of
the referred nut [32]. Therefore, the correct clinical diagnosis
of cashew nut allergy as well as other food allergies should be
made considering data from different indicators, namely the
medical history, the results from diagnostic testing tools (SPT
and serum-specific IgE tests) and food challenges (Fig. 1).
Currently, most food allergic individuals are strongly rec-
ommended to follow a prophylactic measure that consists on
the total avoidance of the allergenic food. However, accidental
exposure to the allergenic food (e.g. cashew nut) or to cross-
reactive ones is frequently occurring, so therapeutic measures
must be applied in those circumstances. Consequently, anti-
histamines are amongst the most frequently prescribed drugs,
followed by epinephrine auto-injectors and systemic corti-
coids [21, 31]. Amongst cashew nut allergic reactions, the
treatment with intramuscular epinephrine is often common
owing to the severity of the allergic reactions (anaphylaxis)
[31]. Treatment with intramuscular epinephrine (into the mid-
outer thigh) is normally the first line of intervention for the
emergency management of an anaphylactic shock [36].
Accordingly, allergic patients at risk of developing anaphylaxis
towards cashew nut or other foods are recommended to carry
with them an epinephrine auto-injector to be use in case of
emergency. This type of auto-injectors (e.g. EpiPen) is nor-
mally prepared to release a dose of intramuscular epinephrine,
but depending on different factors (e.g. patients’ sex, body
habitus), the injection might end up being subcutaneous
[37]. Despite the fact that in most of the cases the subcu-
taneous injection of epinephrine is known to work, the
administration of subcutaneous or inhaled adrenaline in
the treatment of anaphylaxis is not recommended accord-
ing to recent guidelines [36].
The administration of inhaled short-acting beta-2 agonists
(to relieve symptoms of bronchoconstriction) along with ox-
ygen and fluids can be used as a second line of intervention.
Glucocorticosteroids and H1 and H2 antihistamines represent
the third line of treatment for anaphylaxis. Intravenous or oral
glucocorticosteroids are thought to prevent protracted anaphy-
laxis symptoms, especially in patients with concomitant
asthma. The administration of H1 and H2 antihistamines is
only recommended for the relief of cutaneous symptoms of
anaphylaxis (angioedema, urticaria) [36].
More recently, some strategies have been applied aiming at
inducing tolerance to different allergens. Immunotherapy has
been faced as a potential tool to induce immunomodulation
and a desensitisation state in allergic patients, through daily
exposure to increasing doses of the offending food. So far,
some immunotherapies based on different routes of adminis-
tration (subcutaneous, epicutaneous, sublingual and oral) have
been described for the most common allergenic foods, namely
egg, peanut or milk [38–41].
Regarding cashew nut immunotherapy, only few studies
could be found in literature, being mostly carried out in animal
models (mice). Kulis et al. [42] reported that cashew nut im-
munotherapy was effective in protecting mice from allergic
reactions to cashew nut and had a favourable impact on the
walnut challenge in cashew nut/walnut-sensitised mice, lead-
ing to a significant decrease of the allergic symptoms. The
authors also observed that immunotherapy led to increased
cashew nut-specific IgG1 with decreased Th2-type cytokine
production, thus suggesting a potential protective role in vivo
[42]. In a subsequent study, Kulis et al. [43] proposed the use
of pepsinised cashew nut proteins, which elicit weaker allergic
reactions, as highly effective immunotherapy reagents for
treating cashew nut allergy in mice. Like for immunotherapy
Fig. 1 Diagnosis of food (cashew nut) allergy
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with native cashew nut proteins, in immunotherapy with
pepsinised proteins, the levels of IgG1 and IgG2a were in-
creased and the production of Th2-type cytokines decreased
[43], thus proposing the use of hypoallergenic cashew nut
proteins in allergy treatment.
Information on clinical studies involving the administration
of cashew nut to human-allergic patients as immunotherapy is
very limited. One of the reports described the application of
oral immunotherapy to a 22-year-old man with cashew nut,
walnut and peanut allergies, using a daily dose of 0.5 g of total
nut (0.17 g of each offending nut) during 8 months. Levels of
nut-specific IgE increased in the first month but decreased
after 3 and 6 months. The clinical symptoms also decreased
in intensity and frequency along the 8-month treatment [44].
The results evidenced the successful use of immunotherapy to
induce some tolerance to cashew nut, walnut and peanut
allergens upon potential accidental exposure to those nuts.
In a different study that evaluated the ability of omalizumab
(anti-IgE) to induce desensitisation tomultiple allergens, cash-
ew nut was used as one of the test foods [45, 46]. Results from
phase 1 trials seem to indicate that rush oral immunotherapy to
multiple foods with 16 weeks of treatment with omalizumab
could allow a fast desensitisation in subjects with multiple
food allergies. However, the study is still at a preliminary
stage and further understanding about the safety and efficacy
parameters of multi-oral immunotherapy experimental treat-
ments with and without omalizumab is much needed [45].
Clinical Threshold Levels for Cashew Nut Allergy
As part of food allergy diagnosis, individuals with medical
history and/or positive results in vitro/in vivo diagnostic tests
are often challenged to enter OFC or DBPCFC. From these
trials, clinical threshold levels can be characterised for aller-
genic foods at individual basis [47]. So far, several studies
conducted on a variety of allergenic foods evidenced that
individual thresholds or lowest observed adverse effect level
(LOAEL) vary within food allergic population. Considering
that population distribution of minimum eliciting doses (ED)
is estimated to be affected by host- (e.g. genetic predisposi-
tion, environmental factors), food- (e.g. food processing
habits) and population-associated factors (e.g. demographics,
geography), the definition of global threshold levels for
allergenic foods is difficult to achieve [48]. Nonetheless, the
information retrieved from individual threshold levels is
foreseen as valuable data for the definition of population
threshold levels, thus providing guidance for regulatory and
public health agencies, as well as for allergic patients and food
industry [47, 49].
Based on OFC and DBPCFC studies, the threshold levels
of some allergenic foods (peanut, egg or milk) have been
advanced in recent years. However, the determination of
cashew nut threshold doses is still at a preliminary stage. In
a test population of 31 cashew nut allergic children
(<18 years), the minimum dose eliciting objective allergic
symptoms in 5 % (ED05) of the patients corresponded to
7.41 mg of cashew nut protein. When considering any type
of symptoms, the ED05 was 23 times lower, being 0.32 mg of
cashew nut protein [50].
In a different study using DBPCFC on a test population of
179 children (2–17 years), 1 mg of cashew nut protein was
advanced as the minimal eliciting dose for triggering an
allergic reaction [32]. Following a revision of allergen refer-
ence doses, statistical dose distribution models (log-normal,
log-logistic, Weibull) were applied to individual threshold
doses for each allergenic food aiming at defining reference
doses at population level [49, 51]. According to the present
data of ED05 for cashew nut, a reference dose of 2.0 mg of
protein has been provisionally proposed for this allergenic
food [49, 51]. However, until further information regarding
individual threshold levels in cashew nut allergic adults is
available, Crevel et al. [48] recommend considering the refer-
ence dose of 0.1 mg of protein as reference dose for all tree
nuts.
Allergen Characterisation and Clinical Relevance
From the synopsis of allergology and protein evolution, food
allergens have been classified as belonging to a few families
of proteins, according to their structures and biochemical
functions [52]. So far, almost 65 % of the identified plant food
allergens are included in four families of proteins (cupin su-
perfamily, prolamin superfamily, Bet v 1-related proteins and
profilins) [53].
From an immunological point of view, food allergens can
be further categorised as class I or class II, according to their
subjacent pattern of sensitisation. Class I food allergens are
normally considered as presenting high stability to thermal
denaturation, acidic environment and gastrointestinal prote-
ases. Owing to these features, class I food allergens are more
likely to function as sensitizer agents through the gastrointes-
tinal tract, being usually responsible for eliciting moderate to
severe allergic reactions [54]. Seed storage proteins of the
cupin and prolamin superfamilies, namely vicilins, legumins
and 2S albumins, are examples of class I food allergens
[55, 56]. Class II food allergens present less thermal and
digestive stability, thus suggesting that they cannot function
as primary sensitizers. As consequence, the route of sensitisa-
tion occurs via inhaled allergens that lead to the production of
IgE. Class II food allergens are most commonly related to
mild clinical manifestations, although moderate or severe
symptoms might also occur as consequence of adverse immu-
nological responses to these allergens [54]. In the specific case
of cashew nut, the identified allergens are seed storage
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proteins (vicilins, legumins and 2S albumins), which are
classified as class I food allergens.
In terms of clinical presentation, the reported symptoms of
cashew nut allergy are commonly classified as severe and
potentially life-threatening, occurring with complex manifes-
tations that often involve more than one target organ/system.
Accordingly, most of the allergic reactions to cashew nut
evidence skin lesions followed by respiratory and/or gastroin-
testinal symptoms [57]. Mild clinical symptoms such as oral
allergy syndrome are not associated with cashew nut allergy.
Within the sphere of clinical manifestations, urticaria and
angioedema (cutaneous), abdominal pain and vomiting
(gastrointestinal), wheeze, rhino-conjunctivitis, laryngeal
oedema and anaphylaxis are amongst the most classical symp-
toms related to cashew nut allergy [19, 21, 24, 25, 31, 58].
Anaphylaxis is one of the most severe and complex clinical
presentation of an allergic reaction since it normally involves
several systems (cutaneous, respiratory and cardiovascular).
Anaphylaxis is a common clinical presentation of cashew nut
allergy similarly to peanut and other nut allergies [24, 57, 58].
So far, three allergenic groups of proteins have been
identified and characterised in cashew nut, which have been
already included in the World Health Organization/
International Union of Immunological Societies (WHO/
IUIS) official list of allergens [59]. From those, two allergens
belong to the cupin (Ana o 1 and Ana o 2) and one to the
prolamin (Ana o 3) superfamilies of proteins.
Cupin Superfamily
The cupin superfamily presents a wide diversity of proteins,
which can be found in bacteria and eukaryotes, including
plants and animals [60]. Members of this superfamily are
characterised by two short conserved consensus sequence mo-
tifs and a beta-barrel structural core domain, which is the
source of its designation Bcupin^ [61]. Vicilins and legumins
are 7S- and 11S-type globulins, respectively, with two
core domains (bicupins), being considered the major seed
storage proteins in several nuts and legumes [61]. Like in
other nuts, allergenic vicilins and legumins were also
identified in cashew nut.
Ana o 1—Vicilin
Vicilins present a trimeric structure with a total molecular
weight of 150–190 kDa, being characterised by three subunits
of 40 to 80 kDa each [62]. These proteins are composed
of N- and C-terminal domains that are structurally stabilised
by non-covalent hydrophobic interactions, hydrogen bonds
and van der Waals interactions. Vicilins are glycosylated,
presenting one or two N-linked glycosylation sites at
the C-terminal domain, which seem to have a significant
stabilising effect on protein structure [61].
Ana o 1 are the allergenic vicilins identified and characterised
in cashew nut [59, 63], encompassing two isoforms (proteins
with more than 90 % of sequence identity) [64]: Ana o 1.0101
and Ana 1.0102 with 538 and 536 amino acids (aa), encoded by
mRNA sequences of 1810 and 1660 bp, respectively (Table 2).
Using competent Escherichia coli BL21 (DE3) cells, Wang
et al. [65] were able to express recombinant Ana o 1.0101 and
Ana o 1.0102 with molecular sizes of 65 and 55 kDa, respec-
tively, after digestion with thrombin to separate the 43-kDa
maltose-binding protein from the expressed fusion proteins.
Sequence identity and similarity with other vicilins (oil palm,
macadamia nut and walnut) were in the ranges of 33–40 and
54–59 %, respectively. The IgE-binding capacity of these re-
combinant proteins was further evaluated by immunoblotting
with sera from cashew nut allergic patients. As a result, 10 out
the 20 sera from cashew nut allergic patients (50 %) were IgE-
reactive to the recombinant proteins, thus suggesting that Ana
o 1 is a major allergen in cashew nut [65]. In the same study,
the authors also sequenced possible epitopes for Ana o 1 and
evaluated their IgE reactivity with three sets of pooled sera
from different cashew nut allergic patients. From the 11 pep-
tides covering the entire length of the protein, three were
strongly immunoreactive, indicating that they are most likely
immunodominant epitopes [65]. Using the same procedure to
obtain a recombinant Ana o 1, Guan et al. [66] demonstrated
that two of the linear epitope-contributing peptide segments,
which were previously reported by Wang et al. [65], partici-
pate in a conformational epitope. Additionally, the authors
also revealed three new peptide segments that are believed
to function as independent linear epitopes when complexed
with some antibodies and/or together, contributing to one or
more conformational epitopes [66].
More recently, Reitsma et al. [67] were able to extract and
purify native Ana o 1, Ana o 2 and Ana o 3 allergens from
defatted cashew nut flour. Using non-reducing denaturing
conditions by SDS-PAGE and further confirmed by matrix-
assisted laser desorption/ionisation-tandem mass spectrome-
try (MALDI-MS/MS), Ana o 1 was identified as a single
protein of 50 kDa or as a dimer of 100 kDa. The predicted
glycosylation of Ana o 1 was also confirmed by glycoprotein
staining. Besides some cross-reactivity between Ana o 1 and
Ana o 2 (both globulins), minor unexpected cross-reactivity
was observed between Ana o 1 and Ana o 3 allergens [67].
Using molecular modelling, Barre et al. [68] proposed
three-dimensional (3D) models for allergenic vicilins of pea-
nut (Ara h 1), walnut (Jug r 2), hazelnut (Cor a 11) and cashew
nut (Ana o 1). 3D models built for the Jug r 2, Cor a 11 and
Ana o 1 monomers exhibit an overall cupin fold very similar
to that of beta-conglycinin (soybean), by presenting a cupin
motif made of two tandemly arrayed modules. When compar-
ing linear epitopes, Ana o 1 exhibited homology with Ara h 1
and beta-conglycinin, but the highest epitope homology was
observed with vicilins from other nuts, namely Cor a 11
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(hazelnut) and Jug r 2 (walnut) [68]. In in vivo cross-reactivity
assays, cashew nut-sensitised mice reacted to 1 mg of walnut
almost as strongly as to the same quantity of cashew nut, often
experiencing severe anaphylactic reactions.
Clinical symptoms were weaker in cashew nut-sensitised
mice upon challenging with 1 mg of peanut than with equal
amounts of cashew nut or walnut, although symptoms
increased in intensity depending on the dose of peanut used
for the challenge. As a result, Jug r 2 and Ara h 1 were the
cross-reactive allergens implicated in the allergic responses
triggered in cashew nut-sensitised mice [69]. Contrarily to a
previous report stating that there was no cross-reactivity
between cashew nut and peanut allergens [70], Ana o 1 was
also found to be IgE-reactive with human sera of peanut-
allergic patients, thus suggesting cross-reactivity between
Ara h 1 and Ana o 1 allergens [68]. Strong cross-reactivity
of cashew nut with pistachio (both members of the
Anacardiaceae family) has been previously described in cash-
ew nut and/or pistachio-allergic patients [71–73]. Confirming
these clinical evidences, a high overall identity (80 %) and
similarity (90 %) were found between the primary sequences
of Ana o 1 and Pis v 3 (pistachio), with Pis v 3 sharing high
homology in two of the Ana o 1 immunodominant peptides
[74, 75]. In some cashew nut/pistachio allergic patients, cashew
nut seems to act as the primary sensitizer agent in both cashew
nut and pistachio allergies [75].
Ana o 2—Legumin
The legumins or 11S globulins are a different class of func-
tional proteins that belong to the cupin superfamily. Legumins
are multimeric proteins that exist as a mixture of trimers and
hexamers of 50–60 kDa linked by non-covalent interactions
[76]. Each monomer results from the expression of multiple
genes and is synthesised as a single polypeptide, which is then
post-translationally cleaved into two polypeptides—one
acidic (30–40 kDa) and one basic (∼20 kDa)—linked by a
disulphide bond. Contrarily to vicilins, legumins are normally
non-glycosylated proteins. Legumins are seed storage
proteins, representing more than 50 % of protein fraction in
several nuts and legumes [76].
Ana o 2 is the allergenic legumin identified and
characterised in cashew nut [59, 63], comprising one isoform:
Ana o 2.0101 with 457 aa and a molecular size of approxi-
mately 55 kDa, which is encoded by a mRNA sequence of
1671 bp (Table 2). Upon characterisation of the soluble pro-
tein fraction of cashew nut, Teuber et al. [77] identified the
heavy chain of a legumin that present high IgE reactivity
(>50 %) with sera from cashew nut allergic patients.
Accordingly, the protein was designated as Ana o 2 and clas-
sified as a major allergen in cashew nut [77]. Native Ana o 2
was isolated presenting bands of 33, 53 and 120 kDa, which
were estimated to correspond to a heavy chain polypeptide, aTa
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monomer and a dimer of legumin, respectively [78]. Using
non-reducing denaturing conditions by SDS-PAGE and
MALDI-MS/MS, 53-, 30- and 21-kDa bands of Ana o 2 were
confirmed as the complete protein (monomer), large subunit
and small subunit, respectively [67].
Like for the Ana o 1 allergen [65], the recombinant Ana o 2
was also expressed by competent E. coli BL21 (DE3) cells as
a 93-kDa fusion protein with a 43-kDa maltose-binding pro-
tein [78]. Sequence identity and similarity were in ranges of
42–58 and 58–74 %, respectively, with different allergenic
11S globulins, namely Cor a 9 (hazelnut), Jug r 4 (walnut),
Ara h 3 (peanut), Ses i 7 (sesame) and Gly m 6 (soybean)
amongst others [78, 79]. The IgE-binding capacity of recom-
binant Ana o 2 was further evaluated by immunoblotting with
sera from 21 cashew nut allergic patients with clear history of
life-threatening adverse responses to cashew nut. The sera
from 13 patients were IgE-reactive to recombinant Ana o 2,
which represents 62 % of the test population [78], thus
confirming its previous classification as a major allergen of
cashew nut [77]. In the same study, Ana o 2 was sequenced to
determine possible IgE epitopes against pooled sera from
different cashew nut allergic patients. From a total of seven epi-
topes that were strongly IgE-reactive (potential immunodominant
epitopes), six epitopes were located in the acidic polypeptide
[78], suggesting that this region might be predominantly
related to allergenicity.
Linear IgE-binding epitopes were mapped from 3Dmodels
of Ana o 2 (cashew nut), Jug r 4 (walnut), Cor a 9 (hazelnut)
and Ara h 3 (peanut) obtained by homology modelling [80].
Based on the 3D model of Ana o 2, three linear epitopes were
identified on its surface, most of those containing positively or
negatively charged residues, which were predominantly locat-
ed on the acidic face of Ana o 2 trimer. Epitope no. 13 of Ana
o 2 overlaps with one epitope (epitope no. 3) of Ara h 3
(peanut). Both epitopes form a strongly charged area on the
molecular surface of the corresponding allergens and exhibit a
rather conserved overall conformation, despite the moderate
degree of amino acid sequence identity [80]. These common
structural features seem to indicate that linear IgE-binding
epitope no. 13 of Ana o 2 corresponds to a consensual epitope
that also occurs in other nut (Ara h 3, Cor a 9 and Jug r 4) and
plant (G2-glycinin) legumins [79, 80]. Additionally, Ana o 2
displays some exposed residues belonging to linear epitopes
that are predicted to participate in conformational epitopes.
This is the case of some exposed residues of epitope no. 13,
no. 5 and no. 9 that are estimated to be part of a conformational
epitope. Likewise, some residues from epitope no. 21 and no.
22 are also predicted to participate in a unique conformational
epitope located at one extremity of the Ana o 2 protomer [80].
More recently, Robotham et al. [81] confirmed the first Ana o 2
conformational epitope by reactivity with monoclonal anti-
body 2B5, which is located on the large subunit and it is struc-
turally dependent upon association with the small subunit.
With respect to this conformational epitope, both native and
recombinant Ana o 2 reacted similarly upon denaturation de-
spite the structural differences between forms [81, 82].
Lately, Kshirsagar et al. [83] estimated the native sec-
ondary structure of anacardein (Ana o 2) with 49 % of
beta-sheets, 23.7 % of alpha-helices and 27.4 % of ran-
dom coil (absence of regular secondary structure).
Different denaturing conditions (guanidine-HCl, urea,
sodium dodecyl sulphate, beta-mercaptoethanol and
heat—100 °C, 5 min) were used to assess the effect of
structural changes on the immunoreactivity of anacardein
(Ana o 2). As a result, denaturing treatments with sodium
dodecyl sulphate or beta-mercaptoethanol induced conforma-
tional changes, causing a significant reduction in the immu-
noreactivity of anacardein when tested with an antibody that
target conformational epitopes [83]. The addition of oleic acid
to Ana o 2 at a concentration of 5 mM and overnight incuba-
tion at 37 °C induced a 35 % reduction of the IgE-binding
capacity of Ana o 2. This fact seems to suggest that the oleic
acid can reduce the allergenic properties of cashew nut by
binding to its major protein Ana o 2 [84].
Prolamin Superfamily
The prolamin superfamily is one of the most relevant families
of proteins since it encompasses a great number of allergenic
members. Common features, such as the presence of eight
conserved residues of cysteine, high content in proline and
glutamine residues (source of its denomination), low molecu-
lar weight, similar conformational structures rich in alpha-
helices and great stability to thermal processing/proteolysis,
are shared by the members of this superfamily [60]. Contrarily
to legumes and nuts, prolamins are the main storage proteins
in most cereal grains (except in rice and oat) and members of
the grass family [60, 85]. The members of this superfamily
include the 2S albumin seed storage proteins, the non-specific
lipid transfer proteins and the cereal seed inhibitors of alpha-
amylase and trypsin [62].
Ana o 3—2S Albumin
2S albumins represent a family of water-soluble proteins
at low-salt concentrations, presenting a primary structure
with high content in arginine, glutamine, asparagine and
cysteine residues, sharing the same common features of
prolamin members [86]. They are small globular pro-
teins with 12–15 kDa that undergo sequence modifications
after synthesis. Mature 2S albumins are composed by hetero-
dimers, consisting of a large (8–10 kDa) and a small
(3–4 kDa) subunits linked by two conserved inter-chain
disulphide bonds [62, 87, 88]. These proteins have two
additional intra-chain disulphide bonds, which stabilise and
compact their structure. Besides intervening in seed
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germination most likely as nitrogen and sulphur donors,
some 2S albumins are also known to act as antifungal
agents, as serine protease inhibitors and as calmodulin
antagonists [89, 90]. They are considered an important
family of proteins since they are responsible for most
plant food allergies [91].
Ana o 3 is the allergenic 2S albumin identified and
characterised in cashew nut [59, 63]. So far, one isoform,
Ana o 3.0101, has been identified in cashew nut presenting
138 aa and a molecular size of approximately 14 kDa, which
is encoded by a mRNA sequence of 585 bp (Table 2). Besides
identifying a vicilin (Ana o 1) and a legumin (Ana o 2) in the
soluble protein fraction of cashew nut, Teuber et al. [77] also
isolated three small proteins with molecular sizes below
14 kDa (estimated to correspond to a large subunit) that were
classified as 2S albumins. Owing to their high immunoreac-
tivity with sera from cashew nut allergic patients (>73 %),
these proteins were classified as major allergens, being desig-
nated as Ana o 3 [77]. Using competent E. coli BL21 (DE3)
cells, Robotham et al. [92] identified a recombinant Ana o 3
after the purification of the fusion protein (57 kDa) with a
43-kDa maltose-binding protein. The primary structure of
Ana o 3 was evaluated with known sequences of other nut
2S albumins, revealing high degree of identity and
similarity with Pis v 1 (pistachio), Jug n 1 (black walnut),
Jug r 1 (English walnut) and Car i 1 (pecan nut), amongst
others [92, 93]. Ana o 3 evidenced strong IgE reactivity
with sera from 21 out of 26 patients with clear medical
history of moderate to severe allergic reactions upon
cashew nut ingestion [92], thus confirming its previous
classification as major allergen [77].
More recently, Reitsma et al. [67] evaluated Ana o 3 by
SDS-PAGE in denaturing reducing conditions, allowing
detecting three distinct bands at 10, 8 and 6 kDa. Native and
denatured reduced Ana o 3 triplet was further analysed by
liquid chromatography-mass spectrometry (LC-MS). The
bands of 10 and 8 kDa were identified as the large subunit
presenting 8.2–8.4 and 8.1–8.2 kDa, respectively. The band of
6 kDa was recognised as the small subunit of 3.7–4.5 kDa
[67]. Contrarily to Robotham et al. [92], who described that
all three bands were isoforms of the large subunit of Ana o 3
with very similar N-terminal sequences, Reitsma et al. [67]
evidenced that the small and the large subunits of Ana o 3
presented N- and C-terminal micro-heterogeneity and
C-terminal micro-heterogeneity, respectively. This feature is
also common to other allergenic 2S albumins, namely in Ber e
1 (Brazil nut) and Ses i 1 (sesame) [94, 95]. After sequencing,
epitope mapping of Ana o 3 was performed using the sera of 4
cashew nut allergic patients in a total of 42 overlapping
peptides, covering the entire length of the protein. From those,
12 peptides were IgE-reactive to the serum of at least one
cashew nut allergic patient, with the most strongly reactive
peptides being located at the large subunit of Ana o 3 [67].
Effect of Processing and Digestibility on Cashew Nut
Allergens
Presently, there is a wide variety of technologies available for
food processing aiming at improving the organoleptic attri-
butes and/or shelf-life of the product, which is mostly
achieved by removing/inactivating microbial activity and by
altering the properties of different food components [96].
Accordingly, proteins involved in sensitising/eliciting allergic
reactions may undergo extensive modification during food
processing and/or may be present within complex structures
in food. Due to the diversified nature of the allergenic proteins
(e.g. albumins, vicilins, legumins, profilins, nsLTP), their
immunoreactivity is associated with the presence of confor-
mational and/or linear epitopes [97, 98]. If on one side some
thermal treatments are known to reduce the immunoreactivity
of proteins, such as profilins and vicilins, the same processes
cause no effect on proteins, such as 2S albumins or legumins
[98]. On the other side, the formation of novel IgE-binding
sites as a consequence of allergen unfolding (thermal treat-
ment) or chemical/enzymatic modifications can increase their
immunoreactivity [97].
In the specific case of cashew nut, few reports describing
the effect of different food processing treatments on its immu-
noreactivity are available in the literature [70, 99, 100]. de
Leon et al. [70] assessed the effect of roasting (thermal treat-
ment) on the immunoreactivity of cashew nut, verifying that
roasting at 180 °C for 15 min did not affect the IgE-binding
capacity of cashew nut allergens. Su et al. [99] evaluated the
effect of other processing treatments, namely the application
of gamma irradiation or thermal conditions and the combina-
tion of both, on the immunoreactivity of cashew nut allergens.
From different thermal conditions that included autoclaving,
blanching, frying, microwave and roasting, varying the time
and temperature in each of the procedures, only roasting at
160 °C for 30 min reduced IgE-binding of Ana o 2 with rabbit
anti-cashew nut polyclonal antibodies. IgE reactivity was also
strongly reduced in cashew nut subjected to gamma irradia-
tion at 25 kGy followed by autoclaving at 121 °C during
30 min [99].
Venkatachalam et al. [100] also tested the effect of different
thermal (autoclaving, blanching, microwave heating and dry
roasting—varying time/temperature) and pH (1, 3, 5, 7, 9, 11
and 13) conditions as well as gamma irradiation (1–25 kGy)
on the immunoreactivity of cashew nut allergens (Ana o 1,
Ana o 2 and Ana o 3). Two monoclonal antibodies (mAb 4B7
andmAb 1H2) were used to evaluate the reactivity of Ana o 1.
In samples submitted to thermal treatments, the monoclonal
antibody (mAb 4B7) did not detect any band at ∼50 kDa,
although the immunoreactivity was not considerably affected
by gamma irradiation. Contrarily, using the monoclonal anti-
body (mAb 1H2), Ana o 1 was detected in all samples,
although the intensity of the IgE-binding was decreased in the
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sample autoclaved for 20 min. Therefore, Ana o 1 is most
likely to lose its conformational structure upon heat
treatments, although preserving linear epitopes that remain
IgE-reactive. Ana o 1 seems to be stable to pH alterations since
immunoreactivity was only affected in the sample submitted to
pH 13. However, the significance of Ana o 1 instability at this
level of pH is minimal, considering that most methods for
cashew nut processing do not use pH 13 [100].
The immunoreactivity of Ana o 2 after processing simula-
tions was also assessed by one polyclonal (pAb) and two
monoclonal (mAb 4C3 and mAb 4H9) antibodies. Extreme
processing conditions (e.g. autoclaving for 30 min or pH 1)
seemed to enable minor reductions on the IgE reactivity by
pAb-based ELISA (enzyme-linked immunosorbent assay).
The immunoreactivity of Ana o 2 using mAb 4H9 or mAb
4C3 was very similar to the results from pAb, with minor IgE-
binding reduction at extreme pH conditions (pH 1–3 or 13).
Regardless the type of assay or antibody used, Ana o 2 seems
to preserve its structural integrity, which is normally expected
in this family of proteins (legumins) [100].
The monoclonal antibody (mAb D2) used for Ana o 3
recognition did not bind any of its known linear epitopes,
suggesting that it probably recognises a conformational epi-
tope or a potential linear motif that has not yet been identified
in this allergen. Ana o 3 is stable to a pH range of 1–11 but not
detectable at pH 13. Thermal processing, such as autoclaving,
blanching or roasting for 10 min, significantly decreased the
immunoreactivity of Ana o 3 when tested with mAb D2 by
ELISA, which might be related to some structural alterations
(e.g. denaturation) of Ana o 3 [100].
In spite of the distinct nature of cashew nut allergens
(vicilin, legumin and 2S albumin), the majority of the process-
ing conditions did not affect or have little effect on the aller-
genicity of Ana o 1, Ana o 2 and Ana o 3. These results seem
to confirm their great potential for eliciting adverse immuno-
logical responses in sensitised/allergic patients, even after
extensive food processing. Moreover, a general increase in
the intensity of the bands, which is an indicative of increased
immunoreactivity, was observed in samples subjected to
roasting at 170 °C for 20 min. These results might also
indicate that some processing conditions can contribute to
increase, rather than reduce, the immunoreactivity of cashew
nut allergens [100].
More recently, Mattison et al. [101] reported that treating
cashew nut with sodium sulphite disrupted the conformational
structure of Ana o 3, in a temperature-dependent manner. The
structural integrity of Ana o 2 was also disrupted in cashew
nut extracts treated with high concentrations of sodium
sulphite (≥50mM) at high temperatures (≥100 °C). In general,
the immunoreactivity of Ana o 2 and Ana o 3 was greatly
reduced with high concentrations of sodium sulphite
(≥50 mM) and high temperatures (≥100 °C). In the same
study, the authors suggest that sulphating agents (e.g. sodium
sulphite) seem to act at multiple levels in the reduction of IgE-
binding to allergens. Accordingly, by targeting the disulphide
bonds and negatively charging the thiol group, conformational
epitopes are destroyed and linear ones with charged thiols are
most likely to be repelled from IgE-binding sites. As a result,
the incorporation of sodium sulphite or other food-grade
reagents with similar redox potential may be useful to reduce
or eliminate the allergenicity of some proteins [101].
Based on current knowledge relating to gastrointestinal
digestion and food allergies, in vitro assays simulating the
in vivo digestion have been used as predictive tools to assess
the allergenic potential of novel food proteins [102]. In spite of
the increasing number of works detailing the effect of the
simulated gastrointestinal digestion on specific allergenic
foods (e.g. milk, egg, crustaceans), only a report could be
found targeting cashew nut allergens. To mimic the gastric
and intestinal digestion of cashew nut proteins, Mattison
et al. [103] used in vitro assays to assess the effect of gastric
and intestinal fluids on defatted cashew nut flour. Some Ana o
2 peptides were resistant to digestion and remained immuno-
reactive, whilst Ana o 3 peptides seemed to lose some capacity
to bind IgE. However, the study also suggested that Ana o 3
was only partially digested. Ana o 3 is most likely to resist to
both gastric and intestinal digestion, which is consistent with
the stability of other 2S albumins, thus preserving their immu-
noreactivity when reaching the lumen [103].
Management and Traceability of Cashew Nut
Food allergies are considered as an important public health
problem with major impact on the quality of life of
sensitised/allergic individuals [104], representing a current so-
cietal challenge. Faced as a multidisciplinary task, the man-
agement of food allergies requires the involvement of multiple
actors, namely regulatory authorities, different stakeholders
(food industry, clinicians and caretakers) and sensitised/
allergic consumers [105]. Acting at different levels, all entities
share a common feature of protecting the health of sensitised/
allergic individuals. The regulatory authorities and food in-
dustry operate at population level, being responsible for
guaranteeing the protection of public health and for providing
safe foods for all intended consumers, respectively. However,
the ultimate responsibility lies at the individual level, specifi-
cally on the sensitised/allergic consumers, since they are
accountable for all preventive measures regarding the total
avoidance of the allergenic food (and/or cross-reactive ones)
[105]. Therefore, the allergic consumers are fully dependent
on the label information of processed foods, whilst carefully
selecting their nutrient sources. According to recent legisla-
tion, ingredients belonging to the 14 groups of potentially
allergenic foods must be highlighted in the label through a
typeset (font, style or background colour) that clearly
Clinic Rev Allerg Immunol (2019) 57:1–22 11
distinguishes them from the rest of the list of ingredients,
independently of their quantity [11, 12].
Currently, food industry practices precautionary labelling
(e.g. may contain traces of cashew nut) under global legal
directives [11, 12]; therefore, most of the allergic individuals
are protected against the consumption of allergenic foods
[106]. However, accidental exposure to hidden allergens in
foods owing to mislabelling or cross-contaminations during
food processing (e.g. shared production lines) constitutes a
real risk for allergic consumers [107, 108]. To avoid potential
health risks, proper and highly sensitive analytical methodol-
ogies represent essential assets to aid the industrial manage-
ment of allergenic foods and subsequently to facilitate allergen
control/monitoring by the regulatory authorities.
Despite some contradictory opinions regarding the best tar-
get analyte for allergen detection/quantification in foods, there
is a wide spectrum of analytical methods based on proteins
and/or DNA analysis for most of the allergenic food commod-
ities. Nonetheless, the lack of available official methods and
testing/reference materials for their detection/quantification
represents a major shortcoming in food allergen management
[107, 108]. The choice of the best method for allergen analysis
depends on specific criteria, such as target analyte (proteins
versus DNA), basis of detection (e.g. chemical), cost per run/
analysis, setup cost, cross-reactivity, the need for expertise
knowledge and possibility for multi-target detection [109].
For cashew nut analysis, there are several commercial and
in-house-based methods either targeting allergenic/marker
proteins or respective encoding DNA (Fig. 2).
Protein-Based Methods
Considering the advantages and drawbacks associated with all
analytical methods, the classical protein-based methods (later-
al flow devices (LFD), dipstick tests, ELISA, immunoblot-
ting) are the most commonly used for food allergen analysis.
However, other cutting-edge technologies, such as the
immunosensors and theMSplatforms, have also been developed
and applied to allergen detection/quantification in foods.
ELISA and LFD
Based on typical antigen-antibody interaction, ELISA and
LFD offer good sensitivity, adequate specificity and simple
sample handling. ELISA are considered semi-quantitative or
quantitative tools, being the most widely used analytical
Fig. 2 Representative protein- and DNA-based methods for the detection and quantification of cashew nut allergens in foods
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technique for routine analysis and screening of allergens in
foods [110]. LFD are simplified versions of ELISA [110],
which are also quite popular in the food industry, being com-
monly used to check potential cross-contaminations along the
production lines or in the final formulations [107].
Presently, ELISA kits and LFD can be commercially ac-
quired, enabling the detection of a great number of different
allergenic foods. Table 3 summaries the available ELISA kits
and LFD for the specific detection of cashew nut in foods.
These assays can be applied to a wide spectrum of food
matrices with alleged sensitivities of 1–2 or 0.2–1 mg/kg of
cashew nut in foods by LFD or ELISA, respectively. However,
as expected for this type of assays, some cross-reactivity occurs
between cashew nut and other plants, namely with Brazil nut,
pistachio, hazelnut, peanut and walnut (Table 3).
Besides commercial kits, some in-house developed ELISA
have been proposed for the detection of cashew nut in complex
and processed food matrices, namely spices, cereals, choco-
lates, ice creams and cookies (Table 4). ELISA sandwich type
is the most commonly applied, although other formats can be
used (e.g. direct ELISA, indirect ELISA, competitive ELISA).
The reported limits of detection (LOD) for these assays are
aligned with commercial kits, ranging from 0.1 to 1.0 mg/kg
depending on the type of food matrix [111–116]. ELISA
systems can also be performed as a multi-target approach using
the combination of different antibodies in single assays.
Accordingly, an indirect multi-target ELISA was successfully
proposed byRejeb et al. [115] for the simultaneous detection of
peanut and four nuts (cashew nut, almond, hazelnut and Brazil
nut) in milk and dark chocolates (Table 4). In the reported
study, the multi-target ELISA enabled detecting down to
1 mg/kg of cashew nut in milk and dark chocolates [115].
A different commercial immunoassay based on magnetic
beads was performed by Cho et al. [116] for the simultaneous
detection of 14 allergenic foods plus gluten. In the described
method, each allergenic food was combined with micro-
spheres and targeted by two capture antibodies, detecting
raw cashew nut with some cross-reactivity towards hazelnut,
pistachio and Brazil nut.
In spite of all the advantages attributed to immunoassays,
there are several drawbacks that cannot be ruled out. Both
LFD and ELISA are prone to cross-reactivity issues that might
occur frommatrix effects that lead to false positive results and,
upon harsh food processing conditions (heat treatments,
glycation, pH alterations, formation of Maillard products,
fermentation, partial hydrolysis), false negative results are
likely to occur [107].
Immunosensors
Presently, a great attention has been devoted to biosensing
technology, being regarded as one of the most promising
approaches for fast, reproducible, simple and low-cost multi-
target analysis of food allergens. Along with their potential for
automation and high speed of execution, biosensors have been
faced as tools with great potential for real-time allergen
monitoring at an industrial scale [121]. In concept, biosensors
are based on the direct recognition of a biological interaction
between a receptor and a target molecule (proteins or DNA)
by means of a transducer that produces a measurable signal
[110, 122]. This interaction can be registered by different
transducers (optical, piezoelectric or electrochemical) that
are capable of acquiring the signal and further process it to
give a proportional output to the concentration of a specific
target [110].
So far, some biosensors using antibodies as biological re-
ceptors (also known as immunosensors) have been suggested
for food allergen analysis [123]. Rebe Raz et al. [117] devel-
oped a sensor chip as a multi-target approach for the detection
of 12 allergenic foods, including cashew nut. The antibodies
targeting each allergenic food were immobilised onto a sensor
chip as a microarray platform, and the signal acquisition was
performed by an optical transducer (imaging surface plasmon
resonance—iSPR) without requiring labelling or signal ampli-
fication. In the proposed microarray, it was possible to detect
cashew nut down to 0.4 and 0.9 mg/kg in cookies and choco-
lates, respectively (Table 4). The sensitivity of the immunosensor
was in the same range of the ELISA kits (Table 3) and of the in-
house developed ELISA (Table 4), being suggested as excellent
alternatives for multi-target allergen detection.
Mass Spectrometry
The continuous and rapid evolution of proteomic approaches
has turned them as efficient tools for the characterisation of
food-derived proteins. Owing to the impressive increase in the
performance and versatility of MS instrumentation, the devel-
opment of novel analytical strategies for the identification,
characterisation and determination of allergens represents a
valuable platform for food allergenomics [124–126]. MS plat-
forms are normally coupled to a LC system that counts several
advantages, such as high accuracy, sensitivity, specificity and
reproducibility, which have greatly contributed for their appli-
cation in the field of food allergen analysis [126, 127]. In
addition, MS technology allows direct detection of the target
peptide/protein without requiring an interaction with a biolog-
ical receptor (e.g. antibody), which eliminates the problem
related to cross-reactivity phenomena and enables the un-
equivocal identification of target analytes [126].
So far, three MS-based applications have been reported for
the detection and quantification of cashew nut in foods, which
are listed in Table 4. The methods were developed as multi-
target approaches, enabling cashew nut identification and dis-
crimination from other nuts (e.g. almond, walnut, hazelnut) in
different food matrices (biscuits, chocolates, cookies, cakes
and flours) [118–120]. At least, two marker peptides from
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allergenic proteins (Ana o 2, Ana o 3) of cashew nut were used
for its unequivocal identification, showing no cross-reactivity
phenomena with peptides from different nuts (Table 4). In gen-
eral, the limits of detection and quantification (0.5–100 mg/kg)
proposed by the MS methods were higher than those reported
for ELISA kits (0.2–1 mg/kg) (Table 3) or in-house developed
ELISA (0.1–1 mg/kg) (Table 4). Like for other protein-based
methods (e.g. ELISA), the sensitivity attained with MS ap-
proaches was also affected by the food matrix (Table 4).
Accordingly, LOD and LOQ were considerably higher when
targeting cashew nut in difficult food matrices (such as choc-
olates) than in cookies/biscuits [119]. MS-based methods are
excellent alternatives for direct allergen detection/quantifica-
tion, but the high cost ofMS platformmaintenance/equipment
and the need for specialised personnel are main factors
to consider.
DNA-Based Methods
Presently, methodologies based on the detection of DNA for
food allergen analysis have been regarded with increasing
interest. DNA molecules are more likely to preserve their
integrity upon harsh food processing conditions, when
compared to proteins. Therefore, DNA-based methods have
proved to be excellent alternatives to protein-based methods,
especially when analysing highly processed foods. In spite of
being considered as indirect approaches for allergen detection,
DNA-based tools can be easily implemented in routine analy-
ses and considered, at the same time, as confirmatory tools for
the identification of allergenic commodities [107, 108, 128]. In
recent years, DNA-based methods have emerged, demonstrat-
ing their potentialities for food allergen analysis.
Real-Time PCR
Methods based on the polymerase chain reaction (PCR) are
amongst the most commonly used DNA approaches for food
allergen analysis. With adequate setup cost, reasonable
running time and moderate requirements for specialised
equipment and personnel, PCR systems can be used for quan-
tification purposes (e.g. real-time PCR). PCR-based
techniques are also less prone to cross-reactivity phenomena
by carefully selecting the target sequence [107, 108], thus
being independent of possible biological effects associated
with antibody production.
Presently, some real-time PCR kits can be commercially
acquired for food allergen analysis, although at a much small-
er scale than the immunoassays (e.g. ELISA or LFD). Table 3
summarises most of the available real-time PCR kits for the
specific detection of cashew nut in foods. These kits can be
tested in a variety of foods with sensitivities that are strongly
dependent on the type of food matrix analysed. Nonetheless,
the listed kits allege sensitivities down to one to five DNA
genomic copies, which can be comparable to the sensitivities
stated in ELISA kits (Table 3). As expected, by the high spec-
ificity of these kits, no cross-reactivity phenomena are report-
ed for cashew nut.
In addition to the commercial kits, some in-house devel-
oped real-time PCR systems have been proposed for the de-
tection of cashew nut in raw and processed foods (Table 5)
[129–132]. The spectrum of analysed food samples includes
chocolates, biscuits, ice creams, spreads and pesto, amongst
others. For quantitative purposes, most of the developed real-
time PCR systems targeted single copy genes (Ana o 1, Ana o
2 or Ana o 3) (Table 5), since they are considered the best
choices owing to the more constant copy number in different
cells from distinct tissues [122]. However, the sensitivities of
the systems targeting single copy genes are frequently lower
(∼100 mg/kg of cashew nut in matrix) than those using multi-
copy genes (e.g. internal transcribed spacer) (∼0.1 mg/kg of
cashew nut in matrix) (Table 5). As for the commercial kits,
the reported real-time PCR systems also present high specific-
ity for cashew nut without cross-reactivity with other plant
and animal species. Two multiplex real-time PCR have been
proposed as multi-target platforms, enabling detecting cashew
nut from a wide variety of food matrices with high specificity
and sensitivity (Table 5) [133, 134].
LPA
Ligation-dependent probe amplification (LPA) has been pro-
posed for food analysis, particularly for allergen detection.
Basically, the method consists on the amplification of PCR
products that result from the ligation of bipartite specific
hybridisation probes (normally two) and uses a single pair of
PCR primers to amplify several target sequences. A fragment
of unique size is produced after amplification, being discrim-
inated by capillary electrophoresis. The amplification efficien-
cy is similar for all fragments because they are products from
the same set of primers, resulting in a competitive PCR [122].
A LPAwas successfully proposed by Ehlert et al. [135] for
the simultaneous detection of 10 allergenic foods (peanut,
cashew nut, pecan, pistachio, hazelnut, sesame, macadamia
nut, almond, walnut and Brazil nut) in different matrices
(cookies, pesto and chocolates). The specificity of the probes
was evaluated with 56 plant and animal species, thus ensuring
the absence of unspecific amplifications as result of cross-
reactivity. In the case of cashew nut, the multiplex LPA system
enabled its detection down to a level of 5 mg/kg in pesto
matrix (Table 5).
Genosensors/Microarrays
DNA-biosensors (also known as genosensors) have become
excellent tools for the detection of sequence-specific DNA
fragments, mainly due to their simplicity, low-cost, automation
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and high selectivity/specificity. Genosensors share the same
biosensing technology of immunosensors, although they are
based on a different biological interaction. They rely on the
hybridisation of two complementary strands: a probe and its
complementary sequence (RNA or DNA), as the receptor and
target analyte, respectively [122, 123]. Assembling
genosensors in microarray platforms allows the simultaneous
multiple target detection and thus the development of multi-
plex approaches.
A system of optical thin-film biosensor chips coupled to
previous tetraplex PCR amplification was successfully devel-
oped for the simultaneous detection of eight allergenic ingre-
dients (soybean, wheat, peanut, cashew nut, shrimp, fish, beef
and chicken) in processed foods [136]. The proposed micro-
array enabled detecting down to 10 mg/kg of cashew nut in
maize powder and 0.5 pg of genomic DNA (Table 5). No
cross-reactivity was found amongst the species tested in
microarray, being applied to a wide variety of commercial foods.
Final Remarks
Over the last years, cashew nut allergy has been regarded with
special attention since its prevalence seems to be increasing in
the industrialised countries. So far, three groups of seed stor-
age allergenic proteins (Ana o 1—vicilin, Ana o 2—legumin
and Ana o 3—2S albumin) have been identified and
characterised in cashew nut. All proteins have been classified
as major allergens of cashew nut, being included in the WHO/
IUIS official list of allergens. As for other tree nuts, minute
amounts of cashew nut proteins (1 mg) can induce an adverse
immunological response in allergic individuals.
Allergic reactions to cashew nut are commonly severe and
near fatal (anaphylaxis), often demanding epinephrine treat-
ment and hospitalisation, especially in children. The intensity
and severity of allergic reactions are most difficult to predict
due to the influence of several internal and external factors.
Therefore, eliminating the allergenic foods from the diet is still
the most efficient means of preventing allergic reactions in
sensitised/allergic individuals. Accordingly, when carefully
electing the processed foods that are commercially available,
the allergic individuals have to rely on proper food labelling.
Correct label information represents a critical tool for allergen
management. In this sense, the control of labelling compliance
is much needed, which has prompted the development of
proficient analytical methods for allergen analysis.
Contrarily to other pathologies, there is no cure for food
allergies. Although some strategies have been used to induce
immune modulation and subsequent desensitisation, dietary
eviction and the provision of rescue medication in the event
of accidental exposures are the most commonly applied mea-
sures. Different forms of immunotherapies have been tested
aiming at inducing long-term tolerance to the allergenic food.
Oral immunotherapies to induce tolerance to cashew nut are
still very scarce, even though they are foreseen as a potential
therapeutics for the treatment of cashew nut allergy.
In spite of the significant number of available reports
concerning cashew nut allergy, much research is still required
in this field, and new advances are expected in the near future.
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